drugset / Trial / NCT02052557

The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery

NCT02052557 ↗

RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of the study is to evaluate the effect of Exparel on pain control and patient outcome after colon resection. The investigators will evaluate the clinical course of the patients who receive exparel as compared to the patients who do not receive exparel. Exparel is a 72 hour bupivacaine which is slowly released from lysosomes over the course of three days. A long acting local anesthetic should provide better pain control than conventional bupivacaine which has a 3.5 hour half-life.

Timeline

Start
2013-02
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Subcutaneous
Comparator Bupivacaine Other / unclassified 30 ml Subcutaneous